Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (1311-1320 of 1,779) with videos related to

Pageof 178
Sort By:
Mabs|February 10, 2011
IBC's 21st Annual Antibody Engineering and 8th Annual Antibody Therapeutics International Conferences and 2010 Annual Meeting of the Antibody Society. December 5-9, 2010, San Diego, CA USASamantha O Arnett, Jean-Luc Teillaud, Theirry Wurch, et al.
Mabs|December 3, 2010
Functional mapping of the anti-idiotypic antibody anti-TS1 scFv using site-directed mutagenesis and kinetic analysisAnn Erlandsson, Patrik Holm, Rozbeh Jafari, et al.
Mabs|November 6, 2010
Antibody-based therapeutics to watch in 2011Janice M Reichert
Mabs|January 18, 2011
FcRn overexpression in mice results in potent humoral response against weakly immunogenic antigenAttila Végh, Judit Cervenak, István Jankovics, et al.
Mabs|February 3, 2011
A novel platform to produce human monoclonal antibodies: The next generation of therapeutic human monoclonal antibodies discoveryMarcus Duvall, Norma Bradley, Ryan N Fiorini
Mabs|October 12, 2010
ATROSAB, a humanized antagonistic anti-tumor necrosis factor receptor one-specific antibodyKirstin A Zettlitz, Verena Lorenz, Karlheinz Landauer, et al.
Mabs|October 9, 2010
Anti-TNFα domain antibody construct CEP-37247: Full antibody functionality at half the sizeRobert D Gay, Adam W Clarke, Zehra Elgundi, et al.
Mabs|April 14, 2011
Next generation and biosimilar monoclonal antibodies: essential considerations towards regulatory acceptance in Europe. February 3-4, 2011, Freiburg, GermanyJanice M Reichert
Mabs|December 1, 2021
Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody librariesAndre Azevedo Reis Teixeira, Michael Frank Erasmus, Sara D'Angelo, et al.
Mabs|December 20, 2013
Complex mixtures of antibodies generated from a single production qualitatively and quantitatively evaluated by native Orbitrap mass spectrometryNatalie J Thompson, Linda J A Hendriks, John de Kruif, et al.
Pageof 178

Showing results (1311-1320 of 1,779) with videos related to

Sort By:
Pageof 178
Mabs|February 10, 2011
IBC's 21st Annual Antibody Engineering and 8th Annual Antibody Therapeutics International Conferences and 2010 Annual Meeting of the Antibody Society. December 5-9, 2010, San Diego, CA USASamantha O Arnett, Jean-Luc Teillaud, Theirry Wurch, et al.
Mabs|December 3, 2010
Functional mapping of the anti-idiotypic antibody anti-TS1 scFv using site-directed mutagenesis and kinetic analysisAnn Erlandsson, Patrik Holm, Rozbeh Jafari, et al.
Mabs|November 6, 2010
Antibody-based therapeutics to watch in 2011Janice M Reichert
Mabs|January 18, 2011
FcRn overexpression in mice results in potent humoral response against weakly immunogenic antigenAttila Végh, Judit Cervenak, István Jankovics, et al.
Mabs|February 3, 2011
A novel platform to produce human monoclonal antibodies: The next generation of therapeutic human monoclonal antibodies discoveryMarcus Duvall, Norma Bradley, Ryan N Fiorini
Mabs|October 12, 2010
ATROSAB, a humanized antagonistic anti-tumor necrosis factor receptor one-specific antibodyKirstin A Zettlitz, Verena Lorenz, Karlheinz Landauer, et al.
Mabs|October 9, 2010
Anti-TNFα domain antibody construct CEP-37247: Full antibody functionality at half the sizeRobert D Gay, Adam W Clarke, Zehra Elgundi, et al.
Mabs|April 14, 2011
Next generation and biosimilar monoclonal antibodies: essential considerations towards regulatory acceptance in Europe. February 3-4, 2011, Freiburg, GermanyJanice M Reichert
Mabs|December 1, 2021
Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody librariesAndre Azevedo Reis Teixeira, Michael Frank Erasmus, Sara D'Angelo, et al.
Mabs|December 20, 2013
Complex mixtures of antibodies generated from a single production qualitatively and quantitatively evaluated by native Orbitrap mass spectrometryNatalie J Thompson, Linda J A Hendriks, John de Kruif, et al.
Pageof 178